These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 18066827)

  • 1. Design, synthesis, and anti-tumor activity of 4'-thionucleosides as potent and selective agonists at the human A3 adenosine receptor.
    Jeong LS; Lee HW; Kim HO; Jung JY; Gunaga P; Lee SK; Lee EJ; Chun MW; Gao ZG; Jacobson KA; Moon HR
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(10-12):1565-8. PubMed ID: 18066827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and biological activity of N6-substituted-4'-thioadenosines at the human A3 adenosine receptor.
    Jeong LS; Lee HW; Kim HO; Jung JY; Gao ZG; Duong HT; Rao S; Jacobson KA; Shin DH; Lee JA; Gunaga P; Lee SK; Jin DZ; Chun MW; Moon HR
    Bioorg Med Chem; 2006 Jul; 14(14):4718-30. PubMed ID: 16603368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N6-substituted D-4'-thioadenosine-5'-methyluronamides: potent and selective agonists at the human A3 adenosine receptor.
    Jeong LS; Jin DZ; Kim HO; Shin DH; Moon HR; Gunaga P; Chun MW; Kim YC; Melman N; Gao ZG; Jacobson KA
    J Med Chem; 2003 Aug; 46(18):3775-7. PubMed ID: 12930138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationships of truncated D- and l-4'-thioadenosine derivatives as species-independent A3 adenosine receptor antagonists.
    Jeong LS; Pal S; Choe SA; Choi WJ; Jacobson KA; Gao ZG; Klutz AM; Hou X; Kim HO; Lee HW; Lee SK; Tosh DK; Moon HR
    J Med Chem; 2008 Oct; 51(20):6609-13. PubMed ID: 18811138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of potent and selective human A3 adenosine receptor agonists.
    Jeong LS; Lee HW; Jacobson KA; Lee SK; Chun MW
    Nucleic Acids Symp Ser (Oxf); 2005; (49):31-2. PubMed ID: 17150618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of N(6)-substituted-4'-thioadenosine-5'-uronamides as potent and selective human A(3) adenosine receptor agonists.
    Choi WJ; Lee HW; Kim HO; Chinn M; Gao ZG; Patel A; Jacobson KA; Moon HR; Jung YH; Jeong LS
    Bioorg Med Chem; 2009 Dec; 17(23):8003-11. PubMed ID: 19879151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative and improved syntheses of highly potent and selective A3 adenosine receptor agonists, Cl-IB-MECA and thio-Cl-IB-MECA.
    Hou X; Lee HW; Tosh DK; Zhao LX; Jeong LS
    Arch Pharm Res; 2007 Oct; 30(10):1205-9. PubMed ID: 18038898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationships of truncated adenosine derivatives as highly potent and selective human A3 adenosine receptor antagonists.
    Pal S; Choi WJ; Choe SA; Heller CL; Gao ZG; Chinn M; Jacobson KA; Hou X; Lee SK; Kim HO; Jeong LS
    Bioorg Med Chem; 2009 May; 17(10):3733-8. PubMed ID: 19375920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D-4'-thioadenosine derivatives as highly potent and selective agonists at the human A3 adenosine receptor.
    Lee HW; Shin DH; Jeong JY; Kim HO; Chun MW; Melman N; Gao ZG; Jacobson KA; Jeong LS
    Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):607-9. PubMed ID: 16247997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and binding of homologated truncated 4'-thioadenosine derivatives at the human A3 adenosine receptors.
    Lee HW; Kim HO; Choi WJ; Choi S; Lee JH; Park SG; Yoo L; Jacobson KA; Jeong LS
    Bioorg Med Chem; 2010 Oct; 18(19):7015-21. PubMed ID: 20826090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of truncated 4'-thioadenosine derivatives as potent and selective A3 adenosine receptor antagonists.
    Hou X; Pal S; Choi WJ; Kim HO; Tipnis A; Jacobson KA; Jeong LS
    Nucleic Acids Symp Ser (Oxf); 2008; (52):641-2. PubMed ID: 18776543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of a new nucleoside template for human A3 adenosine receptor ligands: D-4'-thioadenosine derivatives without 4'-hydroxymethyl group as highly potent and selective antagonists.
    Jeong LS; Choe SA; Gunaga P; Kim HO; Lee HW; Lee SK; Tosh DK; Patel A; Palaniappan KK; Gao ZG; Jacobson KA; Moon HR
    J Med Chem; 2007 Jul; 50(14):3159-62. PubMed ID: 17555308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of 2-alkynyl substituted 4'-thioadenosine derivatives and their binding affinities at the adenosine receptors.
    Liang CW; Choi WJ; Jeong LS
    Arch Pharm Res; 2008 Aug; 31(8):973-7. PubMed ID: 18787783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel adenosine analog, thio-Cl-IB-MECA, induces G0/G1 cell cycle arrest and apoptosis in human promyelocytic leukemia HL-60 cells.
    Lee EJ; Min HY; Chung HJ; Park EJ; Shin DH; Jeong LS; Lee SK
    Biochem Pharmacol; 2005 Sep; 70(6):918-24. PubMed ID: 16051194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antitumor activity of 5'-deoxy-4'-thio-L-nucleosides.
    Cong L; Zhou W; Jin D; Wang J; Chen X
    Chem Biol Drug Des; 2010 Jun; 75(6):619-27. PubMed ID: 20337785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of A3 adenosine receptor ligands.
    Jeong LS
    Nucleic Acids Symp Ser (Oxf); 2008; (52):79-80. PubMed ID: 18776262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationships of 2-chloro-N6-substituted-4'-thioadenosine-5'-uronamides as highly potent and selective agonists at the human A3 adenosine receptor.
    Jeong LS; Lee HW; Jacobson KA; Kim HO; Shin DH; Lee JA; Gao ZG; Lu C; Duong HT; Gunaga P; Lee SK; Jin DZ; Chun MW; Moon HR
    J Med Chem; 2006 Jan; 49(1):273-81. PubMed ID: 16392812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of inflammation response by a novel A₃ adenosine receptor agonist thio-Cl-IB-MECA through inhibition of Akt and NF-κB signaling.
    Lee HS; Chung HJ; Lee HW; Jeong LS; Lee SK
    Immunobiology; 2011 Sep; 216(9):997-1003. PubMed ID: 21514967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thio-Cl-IB-MECA, a novel A₃ adenosine receptor agonist, suppresses angiogenesis by regulating PI3K/AKT/mTOR and ERK signaling in endothelial cells.
    Kim GD; Oh J; Jeong LS; Lee SK
    Biochem Biophys Res Commun; 2013 Jul; 437(1):79-86. PubMed ID: 23791876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cl-IB-MECA [2-chloro-N6-(3-iodobenzyl)adenosine-5'-N-methylcarboxamide] reduces ischemia/reperfusion injury in mice by activating the A3 adenosine receptor.
    Ge ZD; Peart JN; Kreckler LM; Wan TC; Jacobson MA; Gross GJ; Auchampach JA
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1200-10. PubMed ID: 16985166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.